Similarly, concentrations of CCL3, CCL4, CCL20, CXCL8, and CXCL10 in the NASH group (SMDs of 0.90, 2.05, 2.16, 0.91, and 1.46, respectively) were significantly higher than that in the control group (Table 1B). The gene discussed is CCL4; the disease is metabolic dysfunction-associated steatohepatitis.